Cochrane Abstracts
Selegiline for Alzheimer's disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selegiline for Alzheimer's Disease: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437466/all/Selegiline_for_Alzheimer's_disease:_Cochrane_systematic_review.
Selegiline for Alzheimer's disease: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437466/all/Selegiline_for_Alzheimer's_disease:_Cochrane_systematic_review. Accessed January 31, 2025.
Selegiline for Alzheimer's disease: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437466/all/Selegiline_for_Alzheimer's_disease:_Cochrane_systematic_review
Selegiline for Alzheimer's Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437466/all/Selegiline_for_Alzheimer's_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selegiline for Alzheimer's disease: Cochrane systematic review
ID - 437466
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437466/all/Selegiline_for_Alzheimer's_disease:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
